Determination of polymorph conversion of an active pharmaceutical ingredient in wet granulation using NIR calibration models generated from the premix blends

Journal of Pharmaceutical Sciences

Volumn 94, Issue 12, 2005, Pages 2800-2806

  Li, Weiyong ^a   Worosila, Gregory D ^a   Wang, Wayne ^a   Mascaro, Tracy ^a  

^a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Near infrared spectroscopy; Polymorph; Powder blend; Wet granulation

Indexed keywords

DRUG;

ARTICLE; CALIBRATION; DRUG FORMULATION; DRUG GRANULATION; DRUG STABILITY; HUMIDITY; MODEL; MORPHOLOGY; NEAR INFRARED SPECTROSCOPY; ONLINE SYSTEM; PHYSICAL PARAMETERS; POWDER; QUALITATIVE ANALYSIS; SPECTRUM; TEMPERATURE; WET GRANULATION;

EID: 33144481724     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.20501     Document Type: Article

References (14)

1. Wargo DJ, Drennen JK. 1996. Near-infrared spectroscopic characterization of pharmaceutical powder blends. J Pharm Biomed Anal 14:1415-1423.
2. Forcinio H. 2003. Pharmaceutical industry embraces NIR technology. Spectroscopy 18:16-24.
3. Zhou GX, Ge Z, Dorwart J, Izzo B, Kukura J, Bicker G, Wyvratt J. 2003. Determination and differentiation of surface and bound water in drug substances by near infrared spectroscopy. J Pharm Sci 92:1058-1065.
4. Patel AD, Luner PE, Kemper MS. 2000. Quantitative analysis of polymorphs in binary and multicomponent powder mixtures by near-infrared reflectance spectroscopy. Int J Pharm 206:63-74.
5. Lyon RC, Jefferson EH, Ellison CD, Buhse LF, Spencer JA, Nasr MM, Hussain AS. 2003. Exploring pharmaceutical applications of near-infrared technology. Am Pharm Rev 6:62-70.
6. Li W, Worosila GD. 2005. Quantitation of active pharmaceutical ingredients and excipients in powder blends using designed multivariate calibration models by near infrared spectroscopy. Int J Pharm 295:213-219.
7. Hildrum KI, Isaksson T, Naes T, Tandberg A. 1992. Near infrared spectroscopy-bridging the gap between data analysis and NIR applications, New York: Ellis Horwood Limited.
8. Blanco M, Villar A. 2000. Polymorphic analysis of a pharmaceutical formulation by NIR spectroscopy. Analyst 125:2311-2314.
9. Norris T, Aldridge PK, Sekulic SS. 1997. Determination of end-points for polymorph conversions of crystalline organic compounds using on-line near-infrared spectroscopy. Analyst 122:549-552.
10. Otsuka M, Kato F, Matsuda Y. 2001. Determination of indomethacin polymorphic contents by chemometric near-infrared spectroscopy an conventional powder X-ray diffractometry. Analyst 126:1578-1582.
11. Aldridge PK, Evans CL, Ward HW, Colgan ST. 1996. Near-IR detection of polymorphism and process-related substances. Anal Chem 68:997-1002.
12. Hartauer KJ, Miller ES, Guillory JK. 1992. Diffuse reflectance infrared Fourier transform spectroscopy for the quantitative analysis of mixtures of polymorphs. Int J Pharm 85:163-174.
13. Rohrs BR, Thamann TJ, Gao P, Stelzer DJ, Bergren MS, Chao RS. 1999. Tablet dissolution affected by a moisture mediated solid-state interaction between drug and disintegrant. Pharm Res 16:1850-1856.
14. Suryanarayanan R, Herman CS. 1991. Quantitative analysis of the active ingredient in a multicomponent tablet formulation by powder X-ray diffractometry. Int J Pharm 77:287-295.